Congratulations to New Mexico’s First Cohort of Innovators!
OAM Photonics LLC pursues the development of a compact solid-state coherent optical sensor for long-distance 3D light detection and ranging (LiDAR) with numerous applications including 3D topographic mapping, advanced driver-assistance (ADAS), and autonomous driving. The vision of OAM Photonics is to build novel, smarter and less expensive optical sensors enabled by electronic-photonic integrated circuit (EPIC) technology.
T-NeuroPharma is taking a new approach to Alzheimer’s Disease (AD) diagnosis and treatment. T-Neuro is developing a biomarker to detect early AD in both clinical trial and clinical laboratory settings. Ideally, the biomarker will be utilized to detect the disease early, then the treatment will be administered to prevent the disease from ever progressing. T-Neuro is initially focused on first developing the biomarker for use in clinical trials and in clinical testing laboratories. The development of the therapeutic will follow in Stage II of the Development plan.
Blue Eye Soft is building its Space Anomaly Forensics & Environment Resolution (SAFER) platform to fuse and analyze volumes of historic data to develop predictions of space weather impacts. The NM LEEP collaboration will match Los Alamos’ expertise and capabilities in predicting the behavior of relativistic electrons within the whole outer Van Allen belt with Blue Eye Soft’s predictive analytics and data resources to create the first of its kind forecasting model that provides space weather forecasts to operators and predicts likely radiation damage to satellites impacted by these storms.
We support projects that change our world for the better.
“NM LEEP presents a unique opportunity for Los Alamos National Laboratory and our community to support deep-tech innovators and entrepreneurs.”
-Thom Mason, director of Los Alamos National Laboratory.